Last updated: May 27, 2026
Global supply of potassium phosphate salts is concentrated among a small set of producers of commodity phosphate and phosphate-derivative chemistry. For procurement and supplier qualification, the practical distinction is grade (food, USP/NF, technical, fertilizer) and form (dibasic vs monobasic), with downstream users typically buying via bulk inorganic chemical channels rather than specialized APIs manufacturing networks.
Which companies supply potassium phosphate dibasic and monobasic?
The most reliable supplier set for pharmaceutical-grade procurement typically includes (1) major inorganic chemical manufacturers with established quality systems and (2) global distributors that source from multiple certified plants. For the two products specified:
- Potassium phosphate, dibasic (typically KH₂PO₄? no, that is monobasic; dibasic is commonly K₂HPO₄ in commerce)
- Potassium phosphate, monobasic (commonly KH₂PO₄)
Procurement must align specs to pharmacopeial grades and solution/solid use cases (buffering, sterile irrigation adjuncts, media and excipients).
Key supplier categories for qualification
- Phosphate salt producers (in-house manufacture, controlled impurity profiles, batch documentation)
- Inorganic chemical specialists (frequent USP/NF supply, multiple particle sizes)
- Global distributors (short lead times, catalog breadth; must pass vendor qualification)
What is the USP/NF and pharmaceutical-grade supplier landscape for potassium phosphate salts?
Pharmaceutical-grade potassium phosphate suppliers commonly support USP/NF listings with controlled impurities for:
- Residual metals (heavy metals, specifically Pb, Cd, As, Hg)
- Chloride and sulfate
- Sodium content
- Water content (for certain grades)
- pH and titratable acidity/alkalinity
Compliance signals procurement teams screen
- CoA at lot level for specification adherence
- DMF/CEP/letter of authorization when used in finished dosage manufacturing (varies by buyer and jurisdiction)
- ISO 9001 / ISO 14001 and documented cGMP where applicable
- Change control history and notified specification updates
How many suppliers exist globally for potassium phosphate dibasic (K₂HPO₄) and monobasic (KH₂PO₄)?
The market is global but not fragmented. Manufacturer-level supply is concentrated; distributor-level supply is broad. In practice, most pharmaceutical procurement teams can source from:
- A core group of primary manufacturers (direct or via authorized channels)
- A secondary group of secondary packers and distributors (with lower manufacturing transparency)
Which suppliers are the most common choices for pharmaceutical buyers?
Common procurement pathways for phosphate salts generally include:
- Direct purchase from a primary manufacturer with pharmacopeial grades
- Authorized distribution networks that can provide batch traceability and documentation
For pharmaceutical quality assurance, buyers typically prefer suppliers that can provide:
- consistent grade stability
- lot-to-lot impurity consistency
- rapid access to investigation artifacts (OOS/OOT, deviations)
What certifications and documentation do potassium phosphate suppliers provide for pharmaceutical use?
Pharma-grade inorganic salts are normally supported by:
- Certificate of Analysis (CoA) including test methods used
- Specification sheet aligned to USP/NF monographs
- TSE/BSE statements (where required by buyer policy)
- GMP manufacturing statement or cGMP compliance evidence (varies by supplier)
- CoC and traceability to plant and batch
Common test categories on supplier CoAs
- Identity (phosphate and potassium content)
- Assay/purity
- Related substances (including limits on specific impurities)
- Water content or moisture loss (depending on grade)
- Particle size and sieve (if buyer uses for dissolution/solubility control)
What are typical packaging and storage formats from phosphate salt suppliers?
Suppliers generally ship in:
- Inner bags (often polyethylene-lined) in fiber drums or cartons
- 25 kg / 50 lb bag formats for lab and small manufacturing
- Bulk tanker/IBCs for certain liquid phosphate derivatives, though these two salts are typically shipped as solids
Storage:
- Controlled humidity to prevent moisture uptake (grade dependent)
- Segregated storage to avoid contamination from reactive or chloride-containing materials
How do you qualify a new supplier for potassium phosphate (dibasic/monobasic) for pharma?
A qualification program typically covers:
- Regulatory and quality documents
- CoA history, specification sheet, testing method details
- Quality agreement and change management
- notification windows for impurity spec changes or sourcing changes
- Onboarding technical fit
- particle size, solubility behavior, buffering performance at intended concentration
- Incoming inspection strategy
- receipt sampling plan tied to critical quality attributes
- Stability and compatibility checks
- internal stability and dissolution/USP performance checks where relevant
What generic drug manufacturing uses these suppliers for potassium phosphate salts?
Potassium phosphate salts are widely used as:
- buffering agents in oral and parenteral formulations
- stabilizers for pH control
- components in pharmaceutical processing aids and excipient systems
- media components in microbiological testing and bioprocess workflows (institution-dependent)
Supplier selection affects:
- batch pH control performance
- impurity profile consistency (metals and counterion impurities)
- downstream corrosion or compatibility for equipment (more relevant for solutions)
Which supplier models reduce supply risk for potassium phosphate salts?
For procurement risk management, the most effective structure is:
- dual-source from at least two distinct production plants
- use authorized distributors only if they provide rapid access to plant and lot documentation
- pre-negotiate lead times and minimum order quantities
Key supplier shortlist structure (how to build a “ready-to-procure” vendor pool)
Instead of a “single best supplier,” pharma buyers typically build a pool using:
- 2 to 3 primary manufacturers
- 1 to 2 backup distributors with documented provenance
Your vendor pool is considered complete when each vendor can deliver:
- pharmacopeial-grade material
- lot-level traceability and CoA within defined timeframes
- a quality agreement and deviation/change reporting capability
Key Takeaways
- Potassium phosphate (dibasic, K₂HPO₄) and monobasic (KH₂PO₄) are commodity phosphate salts with pharmaceutical-grade supply driven by a limited set of inorganic chemical producers plus distributor networks.
- Supplier differentiation is primarily by grade compliance (USP/NF or internal specs), impurity profiles, lot consistency, and traceability, not by molecule novelty.
- For high reliability, qualify at least two distinct plant sources and enforce quality agreements covering change control, documentation, and OOS handling.
FAQs
-
Do potassium phosphate monobasic and dibasic suppliers use the same manufacturing plants?
Many producers can supply multiple phosphate salts from adjacent process lines, but plant capability and impurity profiles vary by grade and sourcing controls.
-
What specs matter most when purchasing potassium phosphate salts for buffer formulations?
Impurity limits (metals, chloride/sulfate equivalents), sodium content, water content, and identity/assay consistency.
-
Can distributors supply USP-grade potassium phosphate reliably?
Yes when distributors provide full lot traceability and rapid access to plant CoAs and documentation aligned to USP/NF.
-
What packaging form is preferred for manufacturing and how does it affect quality?
Dry, sealed bulk bags or drums help minimize moisture uptake; buyers often specify moisture sensitivity and sieve/particle requirements.
-
How do supply disruptions typically occur for phosphate salt excipients?
Tightness is driven by global phosphate feedstock availability, transportation constraints, and plant-level grade changeover schedules.
References
- USP-NF Monographs for Potassium Phosphate (Monobasic) and Potassium Phosphate (Dibasic). United States Pharmacopeia.
- FDA Inactive Ingredient Database (IID) entries for potassium phosphate salts (where applicable). U.S. Food and Drug Administration.
- OECD and industry phosphate production background sources (commodity phosphate salt supply context).
